Cited by 113Cholesterol and Lipid MetabolismAdvanced Glycation End Products researchAtherosclerosis and Cardiovascular Diseases

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Scavenger Receptors that Recognize Advanced Glycation End Products

Miyazaki, A·2002·Trends in Cardiovascular Medicine

DOI 10.1016/s1050-1738(02)00171-8

Open this paper in CoChat — free account

Abstract

Scavenger receptors recognize modified low-density lipoproteins (LDLs) such as acetylated LDL and oxidized LDL. Advanced glycation end products (AGE), which are generated through long-term exposure of proteins to glucose, also behave as active ligands for some scavenger receptors, including class A scavenger receptor (SR-A) and class B scavenger receptors such as CD36 and scavenger receptor, class B, type I (SR-BI). SR-BI, the first identified high-density lipoprotein (HDL) receptor, plays key roles in reverse cholesterol transport by promoting selective uptake of cholesteryl esters (CE) in HDL by hepatocytes, and cholesterol efflux of unesterified cholesterol from peripheral cells to HDL. Using Chinese hamster ovary cells overexpressing SR-BI (CHO-SR-BI cells), it was demonstrated that AGE-bovine serum albumin binds to SR-BI and inhibits selective uptake of HDL-CE by CHO-SR-BI cells as well as cholesterol efflux from CHO-SR-BI cells to HDL, suggesting potential roles of AGE in diabetic dyslipidemia and accelerated atherosclerosis in diabetes.

Integrity signals

Registry

Crossref · 10.1016/s1050-1738(02)00171-8

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,545
CD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,282
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,256
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
Suzuki, H. I., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,226
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.
Febbraio, M., Hajjar, D., & Silverstein, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14006 · Cited by 1,171
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,037
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Kodama, T., Freeman, M. W., Rohrer, L., Zabrecky, J. R., Matsudaira, P. T., & Krieger, M. (1990) · Nature · doi:10.1038/343531a0 · Cited by 1,036

Show all 37 references

Sorted by citations

Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 723
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
Mazzone, T., Chait, A., & Plutzky, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60768-0 · Cited by 552
Oxidative Stress in Diabetic Nephropathy
Kashihara, N., Haruna, Y., Kondeti, V., & Kanwar, Y. S. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793348581 · Cited by 478
Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects
Perrone, A., Giovino, A., Benny, J., & Martinelli, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3818196 · Cited by 459
Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury
Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411
Advanced glycation end products and the kidney
Bohlender, J. M., Franke, S., Stein, G., & Wolf, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2004 · Cited by 389
Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases
Byun, K., Yoo, Y., Son, M., Lee, J., Jeong, G.-B., Park, Y. M., Salekdeh, G. H., & Lee, B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.030 · Cited by 357
Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor
Seimon, T. A., Li, Y., Yao, P. M., Stone, E. F., Wang, Y., Davis, R. J., Flavell, R. A., & Tabas, I. A. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200502078 · Cited by 359
Diabetes and Advanced Glycoxidation End Products
Huebschmann, A. G., Regensteiner, J. G., Vlassara, H., & Reusch, J. E. B. (2006) · Diabetes Care · doi:10.2337/dc05-2096 · Cited by 336
Diabetes and atherosclerosis: is there a role for hyperglycemia?
Chait, A., & Bornfeldt, K. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800059-jlr200 · Cited by 298
Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
Borggreve, S. E., Vries, R. D., & Dullaart, R. P. F. (2003) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2003.01263.x · Cited by 277
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.044 · Cited by 243
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
Lu, C., He, J. C., Cai, W., Liu, H., Zhu, L., & Vlassara, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401588101 · Cited by 228
Advanced glycation end‐products and the kidney
Busch, M., Franke, S., Rüster, C., & Wolf, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02317.x · Cited by 228
Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification
Schalkwijk, C. G., Stehouwer, C. D. A., & van Hinsbergh, V. W. M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.488 · Cited by 206
Molecular and cellular aspects of protein misfolding and disease
Herczenik, E., & Gebbink, M. F. B. G. (2008) · The FASEB Journal · doi:10.1096/fj.07-099671 · Cited by 211
Advanced glycation end products and diabetic foot disease
Huijberts, M. S., Schaper, N. C., & Schalkwijk, C. G. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.861 · Cited by 207
Biochemical diversity of odor detection
Vogt, R. G. (2003) · Elsevier eBooks · doi:10.1016/b978-012107151-6/50016-5 · Cited by 202
Intervention against the Maillard reaction in vivo
Monnier, V. M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.014 · Cited by 196
Molecular Basis of Pheromone Detection in Insects
Vogt, R. G. (2005) · Elsevier eBooks · doi:10.1016/b0-44-451924-6/00047-8 · Cited by 178
Scavenger receptors for oxidized and glycated proteins
Horiuchi, S., Sakamoto, Y., & Sakai, M. (2003) · Amino Acids · doi:10.1007/s00726-003-0029-5 · Cited by 178
Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor
Cai, W., He, J. C., Zhu, L., Lu, C., & Vlassara, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600362103 · Cited by 163
Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipoprotein lipids
Connelly, M. A., & Williams, D. L. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00008 · Cited by 162
Maillard reaction in food allergy: Pros and cons
Gupta, R. K., Gupta, K., Sharma, A., Das, M., Ansari, I. A., & Dwivedi, P. D. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1152949 · Cited by 154
A Role for Advanced Glycation End Products in Molecular Ageing
Zgutka, K., Tkacz, M., Tomasiak, P., & Tarnowski, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129881 · Cited by 158
The Clinical Relevance of Advanced Glycation Endproducts (AGE) and Recent Developments in Pharmaceutics to Reduce AGE Accumulation
Smit, A. J., & Lutgers, H. L. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364342 · Cited by 133
Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells
Hilmenyuk, T., Bellinghausen, I., Heydenreich, B., Ilchmann, A., Toda, M., Grabbe, S., & Saloga, J. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03199.x · Cited by 127
Current therapeutic interventions in the glycation pathway: evidence from clinical studies
Engelen, L., Stehouwer, C. D. A., & Schalkwijk, C. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12058 · Cited by 126
The association between metabolic syndrome components and the development of atherosclerosis
Aboonabi, A., Meyer, R. R., & Singh, I. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0273-0 · Cited by 125
Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease
Reynaert, N. L., Gopal, P., Rutten, E. P. A., Wouters, E. F. �., & Schalkwijk, C. G. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.016 · Cited by 113
Advanced Glycation End Products and Diabetic Nephropathy
Thomas, M. C., Forbes, J. M., & Cooper, M. E. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000178769.52610.69 · Cited by 110
Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and “selective” pathway connection
Azhar, S. (2003) · Frontiers in bioscience · doi:10.2741/1165 · Cited by 109
Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells
Stolzing, A., & Grune, T. (2004) · The FASEB Journal · doi:10.1096/fj.03-0374fje · Cited by 107
Protein glycation during aging and in cardiovascular disease
Simm, A. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.05.012 · Cited by 105
The fate of dietary advanced glycation end products in the body: from oral intake to excretion
Liang, Z., Chen, X., Li, L., Li, B., & Yang, Z. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1693958 · Cited by 97
Rapid Plasma Membrane-Endosomal Trafficking of the Lymph Node Sinus and High Endothelial Venule Scavenger Receptor/Homing Receptor Stabilin-1 (Feel-1/Clever-1)
Prevo, R., Banerji, S., Ni, J., & Jackson, D. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406897200 · Cited by 94
Expression of Class A Scavenger Receptor Is Enhanced by High Glucose in Vitro and under Diabetic Conditions in Vivo
Takaki, K., Sakai, M., Sakamoto, Y.-I., Takeya, M., & Horiuchi, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408715200 · Cited by 91
Trends in advanced glycation end products research in diabetes mellitus and its complications
Méndez, J. D., Xie, J., Aguilar-Hernández, M., & Méndez-Valenzuela, V. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0434-5 · Cited by 81
Sensitivity of Cardiac Background Inward Rectifying K+ Outward Current (IK1) to the Alkaloids Lepadiformines A, B, and C
Sauviat, M., Vercauteren, J., Grimaud, N., Jugé, M., Nabil, M., Petit, J.-Y., & Biard, J. (2006) · Journal of Natural Products · doi:10.1021/np050215s · Cited by 73
Current advances in identification of cancer biomarkers in saliva
Arellano, M. L. (2009) · Frontiers in Bioscience-Elite · doi:10.2741/e27 · Cited by 72
AGE-RAGE Axis and Cardiovascular Diseases: Pathophysiologic Mechanisms and Prospects for Clinical Applications
Wang, B., Jiang, T., Qi, Y., Luo, S., Xia, Y., Lang, B., Zhang, B., & Zheng, S. (2024) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07639-0 · Cited by 75
Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers
Galli, F., Benedetti, S., Floridi, A., Canestrari, F., Piroddi, M., Buoncristiani, E., & BUONCRISTIANI, U. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67138.x · Cited by 67
Diabetic Vascular Disease
Goldberg, I. J., & Dansky, H. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000231521.76545.f6 · Cited by 66
High-Density Lipoprotein (HDL) From Elderly and Reconstituted HDL Containing Glycated Apolipoproteins A-I Share Proatherosclerotic and Prosenescent Properties With Increased Cholesterol Influx
Park, K.-H., & Cho, K.-H. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr016 · Cited by 66
Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis
Milioti, N., Bermúdez-Fajardo, A., Penichet, M. L., & Oviedo‐Orta, E. (2008) · Clinical and Developmental Immunology · doi:10.1155/2008/723539 · Cited by 62
Glycation of the Major Milk Allergen β‐Lactoglobulin Changes Its Allergenicity by Alterations in Cellular Uptake and Degradation
Peruško, M., van Roest, M., Stanić-Vučinić, D., Simons, P. J., Pieters, R. H. H., Veličković, T. Ć., & Smit, J. J. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800341 · Cited by 60
Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats
Chatzigeorgiou, A., Kandaraki, E., Piperi, C., Livadas, S., Papavassiliou, A. G., Koutsilieris, M., Papalois, A. E., & Diamanti‐Kandarakis, E. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0175 · Cited by 60
What is the Future of Diabetic Wound Care?
Sweitzer, S. M., Fann, S. A., Borg, T. K., Baynes, J., & Yost, M. J. (2006) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721706286897 · Cited by 60
The Class A Macrophage Scavenger Receptor Attenuates CXC Chemokine Production and the Early Infiltration of Neutrophils in Sterile Peritonitis
Cotena, A., Gordon, S., & Platt, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6427 · Cited by 59
Advanced glycation end products of human β2 glycoprotein I modulate the maturation and function of DCs
Buttari, B., Profumo, E., Capozzi, A., Facchiano, F., Saso, L., Sorice, M., & Riganò, R. (2011) · Blood · doi:10.1182/blood-2010-12-325514 · Cited by 55
Diabetes Mellitus to Accelerated Atherosclerosis: Shared Cellular and Molecular Mechanisms in Glucose and Lipid Metabolism
Zhao, N., Yu, X., Zhu, X., Song, Y., Gao, F., Yu, B., & Qu, A. (2023) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-023-10470-x · Cited by 59
Advanced Glycation End Products(AGE) Inhibit Scavenger Receptor Class B type I-Mediated Reverse Cholesterol Transport: A New Crossroad of AGE to Cholesterol Metabolism.
Ohgami, N., Miyazaki, A., Sakai, M., Kuniyasu, A., Nakayama, H., & Horiuchi, S. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.1 · Cited by 53
Self-citation
Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction
Farhangkhoee, H., Khan, Z. A., Barbin, Y. P., & Chakrabarti, S. (2005) · Diabetologia · doi:10.1007/s00125-005-1801-8 · Cited by 52
Moderate glycation of serum albumin affects folding, stability, and ligand binding
Vetter, S. W., & Indurthi, V. S. K. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.07.022 · Cited by 55
Resveratrol Prevents Dendritic Cell Maturation in Response to Advanced Glycation End Products
Buttari, B., Profumo, E., Facchiano, F., Ozturk, E. I., Segoni, L., Saso, L., & Riganò, R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/574029 · Cited by 48
SR-BI-mediated HDL cholesteryl ester delivery in the adrenal gland
Connelly, M. A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.011 · Cited by 47
T cell proliferative responses to malondialdehyde–acetaldehyde haptenated protein are scavenger receptor mediated
Willis, M. S., Thiele, G. M., Tuma, D. J., & Klassen, L. W. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00136-x · Cited by 44
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
Nenna, A., Spadaccio, C., Lusini, M., Ulianich, L., Chello, M., & Nappi, F. (2016) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/1574890110666151104120039 · Cited by 43
Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes
Nishikawa, M., & Hashida, M. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.355 · Cited by 41
Lipid efflux mechanisms, relation to disease and potential therapeutic aspects
Castaño, D., Rattanasopa, C., Monteiro-Cardoso, V. F., Corlianò, M., Liu, Y., Zhong, A., Rusu, M., Liehn, E. A., & Singaraja, R. R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.013 · Cited by 37
Emodin enhances cholesterol efflux by activating peroxisome proliferator‐activated receptor‐γ in oxidized low density lipoprotein‐loaded THP 1 macrophages
Fu, X., Xu, A., Yao, M., Guo, L., & Zhao, L. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12262 · Cited by 34
High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx
Gantman, A., Fuhrman, B., Aviram, M., & Hayek, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.091 · Cited by 34
Environmental Contaminants and Pancreatic Beta-Cells
Fabricio, G. S., Malta, A., Chango, A., & Mathias, P. C. D. F. (2016) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.2812 · Cited by 30
Prediction of Ion Channel Activity Using Binary Kernel Discrimination
Willett, P., Wilton, D. J., Hartzoulakis, B., Tang, R., Ford, J., & Madge, D. J. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700087v · Cited by 29
Advanced Glycation Endproducts Induce Changes in Glucose Consumption, Lactate Production, and ATP Levels in SH-SY5Y Neuroblastoma Cells by a Redox-Sensitive Mechanism
de Arriba, S. G., Loske, C., Meiners, I., Fleischer, G., Lobisch, M., Wessel, K., Tritschler, H., Schinzel, R., & Münch, G. W. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000090622.86921.0e · Cited by 28
Is carbonyl/AGE/RAGE stress a hallmark of the brain aging?
Semchyshyn, H. M. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02529-y · Cited by 27
Insulin Resistance and Atherosclerosis
Raghavan, V. A. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.014 · Cited by 27
Biodistribution and Elimination Study of Fluorine-18 Labeled Nε-Carboxymethyl-Lysine following Intragastric and Intravenous Administration
Xu, H., Wang, Z., Wang, Y., Hu, S., & Liu, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057897 · Cited by 25
Advanced glycation end products serve as ligands for lectin‐like oxidized low‐density lipoprotein receptor‐1(LOX‐1): biochemical and binding characterizations assay
Chen, X., Zhang, T., & Du, G. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1502 · Cited by 24
Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats
Kim, H. Y., Okamoto, T., & Yokozawa, T. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.04.032 · Cited by 22
Extracellular superoxide released from mitochondria mediates mast cell death by advanced glycation end products
Yoshimaru, T., Suzuki, Y., Inoué, T., Nishida, S., & Ra, C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.08.010 · Cited by 22
The role of AGEs in muscle ageing and sarcopenia
Guo, Z.-J., Li, H., Jiang, S., Rahmati, M., Su, J., Yang, S., Wu, Y., Li, Y., & Deng, Z. (2025) · Bone and Joint Research · doi:10.1302/2046-3758.143.bjr-2024-0252.r1 · Cited by 21
Differential impact of glucose levels and advanced glycation end-products on tubular cell viability and pro-inflammatory/profibrotic functions
Franko, B., Brault, J., Jouvé, T., Beaumel, S., Benhamou, P., Zaoui, P., & Stasia, M. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.042 · Cited by 18
[Glycation and protein crosslinking in the diabetes and ageing pathogenesis].
Cárdenas‐León, M., Díaz‐Díaz, E., Argüelles-Medina, R., Sánchez-Canales, P., Díaz‐Sánchez, V., & Larrea, F. (2009) · PubMed · Cited by 16
Pathological Role of D-amino Acid-Containing Proteins and Advanced Glycation End Products in the Development of Age-Related Macular Degeneration
Kaji, Y., Oshika, T., Takazawa, Y., Fukayama, M., & Fujii, N. (2010) · Anti-aging Medicine · doi:10.3793/jaam.7.107 · Cited by 13
Cryptic epitopes and functional diversity in extracellular proteins
Mortimer, G. M., & Minchin, R. F. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.10.020 · Cited by 12
A Synthetic Peptide-Based Assay System for Detecting Binding between CD36 and an Oxidized Low-Density Lipoprotein
Tsuzuki, S., Takai, M., Matsuno, Y., Kozai, Y., Fujioka, M., Kamei, K., Inagaki, H., Eguchi, A., Matsumura, S., Inoue, K., et al. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.120625 · Cited by 11
Cholesterol ester transfer protein: a therapeutic target in atherosclerosis?
Vourvouhaki, E., & Dedoussis, G. V. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.8.937 · Cited by 9
The dynamic roles of advanced glycation end products
Khalid, M., & Adem, A. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.02.008 · Cited by 11
Role of Advanced Glycation End Products in the Progression of Diabetes Mellitus
Xu, Y., & Guo, H. (2017) · Global Journal of Obesity Diabetes and Metabolic Syndrome · doi:10.17352/2455-8583.000019 · Cited by 9
Les produits de glycation avancée des protéines
Jaisson, S., & Gillery, P. (2018) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(18)30148-5 · Cited by 9
Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review
Zhang, W., Zhao, T., Zhao, Y., Gui, D., & Xu, Y. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190507112157 · Cited by 8
Effects of Advanced Glycation End Products via Oxidative Stress on Beta Cells: Insights from in vitro and in vivo Studies and Update on Emerging Therapies
Anastasiou, I. A., Tentolouris, K. N., Lambadiari, V., Eleftheriadou, I., Tektonidou, M. G., & Tentolouris, N. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230510123038 · Cited by 8
We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis
Orekhov, A. N. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673301236240311113807 · Cited by 6
Enhanced scavenging of lipid substances is a possible effect of corticosteroids in the treatment of cholesterol crystal embolism
Cheng, C., Tsuneyama, K., Zheng, H., Oya, T., Cui, Z., Feril, L. B., & Takano, Y. (2006) · Pathology - Research and Practice · doi:10.1016/j.prp.2006.04.005 · Cited by 6
Hypertension in diabetes: The role of the vasculature
Stern, N., & Marcus, Y. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0082-9 · Cited by 6
Vexed mutations promote degeneration of dopaminergic neurons through excessive activation of the innate immune response
Davis, J., Kolaski, E., & Babcock, D. T. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00417-5 · Cited by 5
Molecular Basis of Pheromone Detection in Insects ☆
Chertemps, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.04038-3 · Cited by 4
ATVB In Focus
Cohen, R. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137187.16206.79 · Cited by 4
AGE-RAGE signalling in endothelial dysfunction and atherosclerosis in diabetes
Watson, A. M. D., Soro‐Paavonen, A., & Jandeleit-Dahm, K. A. M. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0168-9_9 · Cited by 4
The Roles of Protein Glycation, Glycoxidation, and Advanced Glycation End-Product Formation in Diabetes-Induced Atherosclerosis
Rashid, I., Brown, B. E., van Reyk, D. M., & Davies, M. J. (2006) · Springer eBooks · doi:10.1007/0-387-36279-3_12 · Cited by 3
Les xénobiotiques, quel impact sur les maladies métaboliques ?
Laurence Therese, H. U. C., Bortoli, S., & Coumoul, X. (2019) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2019.07.002 · Cited by 3
The AGEs-RAGE axis and nonalcoholic steatohepatitis: the evidence mounts
Yilmaz, Y. N. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0251-3 · Cited by 3
Exploring the therapeutic role of probiotics and prebiotics in mitigating diseases associated with advanced glycation end products
Sun, H., Liu, Z., Li, X., Wen, D., Li, B., & Huang, X. (2025) · Journal of Applied Microbiology · doi:10.1093/jambio/lxaf233 · Cited by 2
Insulin Resistance and Atherosclerosis
Singh, K., & Raghavan, V. A. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_3 · Cited by 2
Ocena stężenia produków zaawansowanej glikacji białek i przeciwciał anty-CEL i anty-CML w surowicy pacjentów chorujących na orbitopatię Gravesa przed i po leczeniu metyloprednizolonem
Strzelczyk, J., Szumska, M., Damasiewicz-Bodzek, A., Krywult, A., Długaszek, M., Czubilińska-Łada, J., Gawlik, K., Synowiec, K., Tyrpień-Golder, K., Poczkaj, K., et al. (2015) · Endokrynologia Polska · doi:10.5603/ep.a2016.0047 · Cited by 2
The fundamental role of obesity management in cardiometabolic risk reduction: nonpharmacological, pharmacological, and surgical approaches
Garvey, W. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00018-8 · Cited by 2
Glycation, Inflammation and RAGE
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2015) · Atherosclerosis · doi:10.1002/9781118828533.ch3
Regulation of macrophage SR-BI by lipoproteins and inflammatory stimuli
Wang, D. Y. C. (2011) · MacSphere (McMaster University) · doi:10.71548/23451

Authors: Miyazaki, A.
Affiliations: Kumamoto University (JP)
Corresponding author: Miyazaki, A
ORCID: Miyazaki, A
Venue: Trends in Cardiovascular Medicine
Publisher: Elsevier BV
Published: 2002-08
Volume: 12
Issue: 6
Pages: 258-262
ISSN: 1050-1738 (ISSN-L)
DOI: 10.1016/s1050-1738(02)00171-8
OpenAlex: W2130961250
Cited by: 113
References: 37
Citations by year: 2026: 1 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 8 · 2015: 2 · 2014: 4 · 2013: 6 · 2012: 4
FWCI: 7.96
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Cardiovascular Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords: advanced glycation end products, scavenger receptors, scavenger receptor class B type I, scavenger receptor A, CD36, modified low-density lipoprotein, high-density lipoprotein, reverse cholesterol transport, cholesteryl ester uptake, cholesterol efflux, diabetic dyslipidemia, atherosclerosis
MeSH terms: Animals, Disease Models, Animal, Cricetinae, Humans, Hyperlipidemias, Membrane Proteins, Receptors, Immunologic, Glycation End Products, Advanced, Receptors, Lipoprotein, CD36 Antigens, Receptors, Scavenger, Scavenger Receptors, Class A, Scavenger Receptors, Class B, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Scavenger Receptors that Recognize Advanced Glycation End Products

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks